MOTS-C 10mg Peptide 99% Lab Tested

MOTS-C (10mg) — Research Overview

MOTS-C is a research-grade mitochondria-derived peptide encoded within the mitochondrial genome, specifically within the 12S rRNA gene. It is part of a class of compounds called mitochondria-derived peptides that has attracted significant research interest since its characterization in 2015.

What the Research Shows

MOTS-C is studied in preclinical research models examining mitochondrial signaling, metabolic pathway regulation, and cellular energy homeostasis. The foundational characterization study by Lee et al. published in Cell Metabolism (2015) documented that MOTS-C regulates metabolic homeostasis in mouse models by targeting skeletal muscle through AMPK pathway activation (PMID: 25738459). A 2019 study in Nature Communications documented MOTS-C translocation to the nucleus under stress conditions where it regulates gene expression related to cellular protection.

Natural plasma concentrations of MOTS-C decline with age. As of 2026, human clinical trial data for MOTS-C is extremely limited. The compound is not approved by the FDA for human or veterinary therapeutic use. All primary findings come from animal models and cell culture studies.

Quality Documentation

• 99%+ purity — HPLC and Mass Spectrometry verified
• 10mg MOTS-C lyophilized powder
• Batch-specific COA included with every order
• USA tested and fulfilled

For laboratory research purposes only. Not for human or veterinary consumption.